Dr. Gabriel is Professor of Medicine and of Epidemiology and an established NIH-funded investigator in the epidemiology of the rheumatic diseases. Dr. Gabriel has successfully integrated her knowledge of clinical rheumatology with her training in epidemiology and health services research to develop a research program that has made important contributions to our understanding of the risks, determinants, and outcomes of the rheumatic diseases. A few highlights include her many publications on the risks, costs, and cost-effectiveness of nonsteroidal anti-inflammatory drugs (NSAIDs), her well-known epidemiologic studies examining the risks of connective tissue diseases among women with breast implants, her population-based studies characterizing the epidemiology of nearly all the major rheumatic diseases (e.g. RA, JRA, SLE, GCA, PMR, psoriatic arthritis, localized scleroderma), and her studies defining the economic impact of RA. Most recently her research has focused on elucidating the risks and determinants of heart disease among persons with Rheumatoid Arthritis.